BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31505165)

  • 1. LncRNA SNHG3 promotes clear cell renal cell carcinoma proliferation and migration by upregulating TOP2A.
    Zhang C; Qu Y; Xiao H; Xiao W; Liu J; Gao Y; Li M; Liu J
    Exp Cell Res; 2019 Nov; 384(1):111595. PubMed ID: 31505165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA MIR4435-2HG promoted clear cell renal cell carcinoma malignant progression via miR-513a-5p/KLF6 axis.
    Zhu K; Miao C; Tian Y; Qin Z; Xue J; Xia J; Zhu S; Xu A; Yang J; Wang Z
    J Cell Mol Med; 2020 Sep; 24(17):10013-10026. PubMed ID: 33460239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CircPVT1 promotes progression in clear cell renal cell carcinoma by sponging miR-145-5p and regulating TBX15 expression.
    Zheng Z; Chen Z; Zhong Q; Zhu D; Xie Y; Shangguan W; Xie W
    Cancer Sci; 2021 Apr; 112(4):1443-1456. PubMed ID: 33453148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
    Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
    Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LINC01426 contributes to clear cell renal cell carcinoma progression by modulating CTBP1/miR-423-5p/FOXM1 axis via interacting with IGF2BP1.
    Jiang Y; Zhang H; Li W; Yan Y; Yao X; Gu W
    J Cell Physiol; 2021 Jan; 236(1):427-439. PubMed ID: 32583425
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Liu Q; Lei C
    Ann Med; 2021 Dec; 53(1):2153-2164. PubMed ID: 34783622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking lncRNA MIR155HG/miR-155-5p/-3p inhibits proliferation, invasion and migration of clear cell renal cell carcinoma.
    Tao M; Zhou Y; Jin Y; Pu J
    Pathol Res Pract; 2020 Feb; 216(2):152803. PubMed ID: 31889587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA FAM230B Promotes Gastric Cancer Growth and Metastasis by Regulating the miR-27a-5p/TOP2A Axis.
    Cui Y; Pu R; Ye J; Huang H; Liao D; Yang Y; Chen W; Yao Y; He Y
    Dig Dis Sci; 2021 Aug; 66(8):2637-2650. PubMed ID: 32910366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA PENG upregulates PDZK1 expression by sponging miR-15b to suppress clear cell renal cell carcinoma cell proliferation.
    Qi Y; Ma Y; Peng Z; Wang L; Li L; Tang Y; He J; Zheng J
    Oncogene; 2020 May; 39(22):4404-4420. PubMed ID: 32341409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic role and potential regulatory mechanism of topoisomerase IIα in a pan-cancer analysis.
    Wang X; Wang J; Lyu L; Gao X; Cai Y; Tang B
    Sci Rep; 2022 Jul; 12(1):11161. PubMed ID: 35778520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA DLEU1 accelerates the malignant progression of clear cell renal cell carcinoma via regulating miRNA-194-5p.
    He GZ; Yu SY; Zhou QP; Chen ML; Zhang YW; Zheng Y; Zhang ZB; Han ZY; Yu J
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10691-10698. PubMed ID: 31858537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway.
    Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J
    Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non‑coding RNA‑DUXAP8 regulates TOP2A in the growth and metastasis of osteosarcoma via microRNA‑635.
    Yang T; Guo JP; Li F; Xiu C; Wang H; Duan XL
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33982765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The miR-140-5p/KLF9/KCNQ1 axis promotes the progression of renal cell carcinoma.
    Huang C; Li J; Zhang X; Xiong T; Ye J; Yu J; Gui Y
    FASEB J; 2020 Aug; 34(8):10623-10639. PubMed ID: 32596959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMGA1-mediated miR-671-5p targets APC to promote metastasis of clear cell renal cell carcinoma through Wnt signaling.
    Chi XG; Meng XX; Ding DL; Xuan XH; Chen YZ; Cai Q; Wang A
    Neoplasma; 2020 Jan; 67(1):46-53. PubMed ID: 31686521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer.
    Liu S; Wang Y; Li W; Yu S; Wen Z; Chen Z; Lin F
    Biomed Pharmacother; 2019 Nov; 119():109406. PubMed ID: 31514066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-212-5p inhibits the malignant behavior of clear cell renal cell carcinoma cells by targeting TBX15.
    Deng JH; Zheng GY; Li HZ; Ji ZG
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10699-10707. PubMed ID: 31858538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-182-5p inhibits the tumorigenesis of clear cell renal cell carcinoma by repressing UBE2T.
    Wu Y; Zhang C; Peng D; He S; Huang C; Qian J; Zhu W; Feng N; Gong Y; Li X; Zhou L
    Hum Cell; 2022 Mar; 35(2):542-556. PubMed ID: 35129808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-483-5p downregulation contributed to cell proliferation, metastasis, and inflammation of clear cell renal cell carcinoma.
    Wang XG; Zhu YW; Wang T; Chen B; Xing JC; Xiao W
    Kaohsiung J Med Sci; 2021 Mar; 37(3):192-199. PubMed ID: 33151036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA SNHG3 promotes bladder cancer proliferation and metastasis through miR-515-5p/GINS2 axis.
    Dai G; Huang C; Yang J; Jin L; Fu K; Yuan F; Zhu J; Xue B
    J Cell Mol Med; 2020 Aug; 24(16):9231-9243. PubMed ID: 32596993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.